Oral contraceptive use and risk of melanoma in premenopausal women
1999

Oral Contraceptive Use and Melanoma Risk in Women

Sample size: 183693 publication Evidence: moderate

Author Information

Author(s): Feskanich D, Hunter D J, Willett W C, Spiegelman D, Stampfer M J, Colditz G A

Primary Institution: Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School

Hypothesis

Does oral contraceptive use increase the risk of melanoma in premenopausal women?

Conclusion

Current oral contraceptive users may have an increased risk of melanoma, especially with longer use.

Supporting Evidence

  • A significant twofold increase in melanoma risk was observed among current OC users compared to never users.
  • Risk increased to 3.4 times for those using OC for 10 or more years.
  • No elevated risk was found among past OC users.

Takeaway

Using birth control pills might make some women more likely to get skin cancer called melanoma, especially if they use them for a long time.

Methodology

The study analyzed data from the Nurses’ Health Study and Nurses’ Health Study II, assessing melanoma cases and various risk factors.

Potential Biases

Potential biases may arise from self-reported data on contraceptive use and melanoma diagnoses.

Limitations

The study may not account for all potential confounding factors related to melanoma risk.

Participant Demographics

The study involved premenopausal white women.

Statistical Information

Confidence Interval

95% CI 1.2–3.4

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690787

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication